A groundbreaking FDA approval has introduced a new treatment option specifically designed for colorectal cancer patients with ...

A Japanese research team has discovered new evidence on how genes function in the large intestine, a move that could shed light on why colorectal cancer often develops on the left side. Colorectal ...

This is a significant departure from traditional cancer treatments that rely on killing cancer cells, often leading to severe ...

Using a computational “digital twin” model, researchers mapped the gene networks controlling cell differentiation. They ...

Despite advancements in cancer treatment technologies, most therapies share a common goal: eliminating cancer cells. However, ...

Researchers highlight GPT1 enzymes role in slowing colon cancer progression Researchers uncover new insights into the ...

and genetics can all increase the risk of bowel cancers Genetics is a major risk factor for colon cancer. There's evidence that bowel cancers are more likely in younger people with a family ...

Scientists uncover how disrupted lipid metabolism fuels chronic inflammation in colorectal cancer, offering insights into new therapeutic strategies targeting pro-inflammatory and pro-resolving lipid ...

Larotrectinib sulfate is under clinical development by Bayer and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II drugs for Colorectal Cancer have a 25% phase transition ...